| __timestamp | Geron Corporation | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 55430000 |
| Thursday, January 1, 2015 | 17831000 | 65510000 |
| Friday, January 1, 2016 | 18047000 | 71160000 |
| Sunday, January 1, 2017 | 11033000 | 70644000 |
| Monday, January 1, 2018 | 13432000 | 70418000 |
| Tuesday, January 1, 2019 | 52072000 | 63238000 |
| Wednesday, January 1, 2020 | 51488000 | 59777000 |
| Friday, January 1, 2021 | 85727000 | 60152000 |
| Saturday, January 1, 2022 | 95518000 | 54540000 |
| Sunday, January 1, 2023 | 125046000 | 52243000 |
| Monday, January 1, 2024 | 64536000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Geron Corporation and Taro Pharmaceutical Industries Ltd. have been at the forefront of this race, each investing significantly in research and development (R&D) over the past decade. From 2014 to 2023, Taro consistently allocated a substantial portion of its budget to R&D, peaking in 2016 with a 71% increase from 2014. Meanwhile, Geron Corporation's investment strategy saw a dramatic shift, with a staggering 505% increase in R&D spending from 2017 to 2023. This surge highlights Geron's commitment to innovation, especially in recent years. However, Taro's steady investment underscores its long-term dedication to research. As we look to the future, the missing data for 2024 leaves us curious about the next steps for these industry leaders. Will Geron maintain its upward trajectory, or will Taro reclaim its dominance in innovation spending?
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Amgen Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
R&D Insights: How CymaBay Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Geron Corporation
R&D Insights: How Veracyte, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs Geron Corporation
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored